Anastrozole: observed
63 studies: patients on it are followed, or it is given outside a trial. Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in RussiaRecruitingNCT06930859How we knowReport a problem
- Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world PracticeRecruitingNCT06905301How we knowReport a problem
- A Retrospective Real-world Study of Abemaciclib in HR+ Breast CancerNot yet recruitingNCT06341283How we knowReport a problem
- Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint TumorNot yet recruitingNCT06154590How we knowReport a problem
- Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World StudyNot yet recruitingNCT05801705How we knowReport a problem
- Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine TherapyRecruitingNCT04476485How we knowReport a problem
- Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.CompletedNCT06086340Results postedHow we knowReport a problem
- Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast CancerCompletedNCT01896050Results postedHow we knowReport a problem
- Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer PatientsCompletedNCT01814397Results postedHow we knowReport a problem
- Changes in Knee Articular Cartilage Volume in Women on Aromatase InhibitorsCompletedNCT00111241Results postedHow we knowReport a problem
- Trifecta Research StudyActive, not recruitingNCT07717866How we knowReport a problem
- Emulation of the MONARCH-3 Trial Using Specialty Oncology Electronic Health Records DatabasesCompletedNCT07225790How we knowReport a problem
- A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast CancerActive, not recruitingNCT06495164How we knowReport a problem
- A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line TreatmentCompletedNCT06311383How we knowReport a problem
- Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in RussiaStatus unknownNCT05800197How we knowReport a problem
- Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia.CompletedNCT05789771How we knowReport a problem
- Pilot Observational Study Examining the Effect of Endocrine Therapy on AgingCompletedNCT05700006How we knowReport a problem
- Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/LetrozoleCompletedNCT05635357How we knowReport a problem
- Efficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast CancerStatus unknownNCT04891731How we knowReport a problem
- Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.Status unknownNCT04852081How we knowReport a problem
- First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.Active, not recruitingNCT04767594How we knowReport a problem
- Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the BreastStatus unknownNCT04666805How we knowReport a problem
- Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast CancerStatus unknownNCT04389424How we knowReport a problem
- Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line ChemotherapyCompletedNCT04258163How we knowReport a problem
- Breast Cancer Treatment Based on Organ-like CultureStatus unknownNCT03925233How we knowReport a problem
- Testosterone Implants and the Incidence of Breast CancerCompletedNCT03768258How we knowReport a problem
- Treatment After Progression of Fulvestrant Among Metastatic Breast Cancer PatientsCompletedNCT03541863How we knowReport a problem
- Retrospective Analysis of Effectiveness and Safety Profile of Anastrozole and Letrozole in HR+ Breast Cancer PatientsStatus unknownNCT02812277How we knowReport a problem
- Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer PatientsStatus unknownNCT02765373How we knowReport a problem
- Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted TherapyCompletedNCT02753686How we knowReport a problem
- Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal DatabaseCompletedNCT01937052How we knowReport a problem
- Long-term Anastrozole Versus Tamoxifen Treatment EffectsCompletedNCT01745289How we knowReport a problem
- Oral Health in Breast Cancer Survivors on Aromatase InhibitorsCompletedNCT01693731How we knowReport a problem
- Predictive Model of Therapy Outcomes in Breast Cancer PatientsCompletedNCT01563211How we knowReport a problem
- Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer SurvivorsCompletedNCT01272570How we knowReport a problem
- Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast CancerCompletedNCT01207635How we knowReport a problem
- Radiotherapy - Anastrazole Concomitant : Evaluation of the Side EffectsCompletedNCT01183832How we knowReport a problem
- Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment AdherenceCompletedNCT01081509How we knowReport a problem
- The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast CancerCompletedNCT01080170How we knowReport a problem
- CYP19 Genetic Polymorphism & Aromatase Inhibitor(AI)Status unknownNCT00973505How we knowReport a problem
- Arimidex Therapy Compliance Electronic Monitoring SystemCompletedNCT00936442How we knowReport a problem
- Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast CancerCompletedNCT00884143How we knowReport a problem
- Retrospective Survey of Bone Fracture in Patients With Arimidex 1mgCompletedNCT00859560How we knowReport a problem
- Arimidex: Compliance and Arthralgias in Clinical Therapy (COMPACT)CompletedNCT00857012How we knowReport a problem
- Arimidex Bone Mass Index and Oral BisphosphonatesCompletedNCT00809484How we knowReport a problem
- Anastrozole and LetrozoleCompletedNCT00762294How we knowReport a problem
- An Observational Study of Adherence to Anastrozole in Early Breast Cancer TreatmentCompletedNCT00737009How we knowReport a problem
- Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast CancerCompletedNCT00719966How we knowReport a problem
- Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast CancerCompletedNCT00692289How we knowReport a problem
- Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone TherapyCompletedNCT00681928How we knowReport a problem
- Breast Cancer Tumor Care Observational ProgrammeCompletedNCT00660244How we knowReport a problem
- Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast CancerCompletedNCT00638391How we knowReport a problem
- Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With AnastrozoleCompletedNCT00623519How we knowReport a problem
- Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast CancerCompletedNCT00562458How we knowReport a problem
- Electronic Study for Anastrozole Pharmacovigilance EvaluationCompletedNCT00558168How we knowReport a problem
- Patient's Anastrozole Compliance to Therapy ProgrammeTerminatedNCT00555867How we knowReport a problem
- Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant TherapyTerminatedNCT00542594How we knowReport a problem
- Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast CancerCompletedNCT00516698How we knowReport a problem
- Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed AnastrozoleCompletedNCT00421447How we knowReport a problem
- Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or AnastrozoleCompletedNCT00316836How we knowReport a problem
- Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast CancerCompletedNCT00283608How we knowReport a problem
- Arimidex Observational: Reason for and Effect of Change From TamoxifenCompletedNCT00246961How we knowReport a problem
- Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast CancerCompletedNCT00090974How we knowReport a problem